细菌感染在慢性阻塞性肺疾病急性加重中的作用研究

　　[12] Anthonison NR. The British hypothesis revisited. Eur Respir J,2004,23:657～658.

　　[13] Noguera A,Battles S,Miralles C,et al.Enhanced neutrophil response in chronic obstructive pulmonary disease.Thorax,2001,56:432～437.

　　[14] Danesh J,Collins R,Appleyby P,et al.Association of fibrinogen,C-creative protein ,albumin or leukocyte count with coronary heart disease:meta-analyses of prospective studies.JAMA,1998,279(18):1　477～1　482.

　　[15] Sethi S,Muscarella K,Evans N,et al.Airway inflammation and etiology of acute exacerbations of chronic bronchitis[J].Chest,2000,118(6):1　557～1　565.

　　[16] Hill AT,Campbell EJ,Hill SL,et al.Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis[J].Am J Med,2000,109(4):288～295.

　　[17] Gendrel D,Bohuon C. Procalcitonin as a marker of bacterial infection[J].Pediatr Infect Dis J,2000,19(8):679～688.

　　[18] Nylen E, Muller B, Becker KL. The future diagnostic role of procalcitonin levels: the need for Imp roved sensitivity[J].Clin Infect Dis,2003,36(6):826～827.

　　[19] Hausfater P, Garric S, Ayed SB, et al.Usefulness of procalcitoninas a marker of systemic infection in emergency department patients: a prospective study[J].Clin Infect Dis,2002,34:895～901.

　　[20] Christ-CrainM, Jaccard-Stolz D, Bingisser R. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial[J].Lancet,2004,363:600～607.

　　[21] Murphy TF,Set hi S,Niederman MS.The role of bacteria inexacerbations of COPD. A constructive view.Chest,2000,118(1):204～209.

　　[22] Prieto A,Reyes E,Bernstein ED,et al.Defective natural killerand phagocytic activities in chronic obstructive pulmonarydisease are restored by glycophosphopeptical(Inmun

上一页  [1] [2] [3] [4] [5] 下一页